Diabetic Retinopathy Market Size, Share, Trends, Analysis and Forecast 2019-2025

The global diabetic retinopathy market is estimated to grow at a CAGR of over 6% during the forecast period. The eye disease associated with diabetic patients is diabetic retinopathy. It occurs when there is long term diabetes and which damages the retina. Without timely treatment, the disease may lead to various impairments in eyes such as cloudy vision, bleeding in the eyes, and can even permanently damage the retina and can eventually lead to blindness.

The factors that primarily drive the growth of the global diabetic retinopathy industry include, rising prevalence of diabetes, rise in geriatric population, growth in incidence of blindness due to diabetes, and focus on increasing awareness that facilitates early diagnosis to control the diseases. However, some of the factors such as extended approval time for drugs and high costs of treatment that challenge the growth of the global diabetic retinopathy market.

A full report of Global Diabetic Retinopathy Market is available at https://www.omrglobal.com/industry-reports/diabetic-retinopathy-market

Further, based on the management segment of the global diabetic retinopathy market, the Anti-VEGF holds the most considerable share in the market. This is attributed to the high applicability of the drug in the treatment of diseases for early diagnosis and faster recovery. Lucentis is among one of the most commonly used anti-VEGF as its favorable outcomes. Thus, anti-VEGF is likely to register growth in the market.

Moreover, the laser is also a highly effective treatment method, due to which it is also preferred amongst patients. Thus, the technological advancement and availability of advanced and improved drugs and equipment are further projected to foster segmental growth global diabetic retinopathy market during the forecast period. Based on geography, North America is estimated to hold considerable share followed by Europe, attributing to the expanding healthcare infrastructure along with favorable reimbursement framework in the region.

To learn more about this report request a free sample copy at https://www.omrglobal.com/request-sample/diabetic-retinopathy-market

Besides, F. Hoffmann-La Roche AG, Boehringer Ingelheim International GmbH, Bayer AG, Novartis International AG, Regeneron Pharmaceuticals Inc., Oxurion N.V.,and Pfizer Inc.are among the key companies of the market, that are adopting several organic and inorganic growth strategies such as product launches & developments, partnerships, agreements, and acquisitions to strengthen their existing product line and maintain a competitive position in the global diabetic retinopathy market. Also, the companies are adopting novel AI-based methods for the diagnosis and treatment of the eye of patients suffering from long term diabetic retinopathy.

Current Market Trends Covered in the Market Report:

o Increased investments in the healthcare infrastructure and development of novel diabetes treatment options are positively affecting the diabetic retinopathy market growth
o The anti-VGEF segment will account for significant growth in the market
o Increase in consumer awareness towards the treatment of the diseases is expected to provide a growth rate to the diabetic retinopathy market
o Asia-Pacific region will register a significant growth rate in the market across the globe
o The development of novel drugs and treatment methods will be the key strategy adopted by the players

Global Diabetic Retinopathy Market - Segmentation

By Type

o Proliferative Diabetic Retinopathy
o Non-Proliferative Diabetic Retinopathy

By Management

o Anti-VEGF
o Intraocular Steroid Injection
o Laser Surgery
o Vitrectomy

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/diabetic-retinopathy-market

Global Diabetic Retinopathy Market - Segment by Region

North America

o United States
o Canada

Europe

o Germany
o United Kingdom
o France
o Spain
o Italy
o Rest of Europe

Asia-Pacific

o China
o Japan
o India
o Rest of Asia-Pacific

Rest of the World

o Middle East & Africa
o Latin America

Company Profiles

o Alimera Sciences Inc.
o Allergan Plc
o Ampio Pharmaceuticals Inc.
o Bayer AG
o Bausch Health Companies Inc.
o Boehringer Ingelheim International GmbH
o EyePACS LLC
o F. Hoffmann-La Roche Ltd.
o Genentech Inc.
o Glycadia, Inc.
o KOWA Co. Ltd.
o Kubota Vision Inc.
o LumiThera Inc.
o Novartis International AG
o Oxurion NV
o Pfizer Inc.
o Regeneron Pharmaceuticals Inc.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.